Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Dana Jean La Haie

Psychiatry Phoenix, AZ Medical Doctor

NPI 1669679288 CMS profile 382260

4435 E Chandler Blvd Ste 200, Phoenix, AZ 85048

Open in the dashboard

General payments

$6,379

360 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Dana Jean La Haie of Phoenix, AZ is reported in the CMS Open Payments database as having received $6,379 across 360 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $1,026 53
2022 General $1,993 110
2021 General $1,757 97
2020 General $605 36
2019 General $998 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dana Jean La Haie
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Dana Jean La Haie were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Dana Jean La Haie Psychiatry median Middle half National median
2019 $998 $184 $59–$605 $163
2020 $605 $119 $36–$372 $114
2021 $1,757 $143 $43–$576 $132
2022 $1,993 $153 $50–$590 $149
2023 $1,026 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Otsuka America Pharmaceutical, Inc. $744 42 payments
  2. Sunovion Pharmaceuticals Inc. $725 37 payments
  3. AbbVie, Inc. $546 39 payments
  4. Corium, Inc. $466 30 payments
  5. Ironshore Pharmaceuticals Inc. $443 25 payments
  6. ITI, Inc. $393 20 payments
  7. Janssen Pharmaceuticals, Inc $375 18 payments
  8. Tris Pharma Inc $347 22 payments
  9. Lundbeck LLC $300 18 payments
  10. Takeda Pharmaceuticals U.S.A., Inc. $299 21 payments
  11. Other $1,740 88 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $6,338 357 payments
  2. Education $41 3 payments
Products named General payments · program years 2019–2023
  1. LATUDA $725 37 payments
  2. VRAYLAR Neuroscience $546 39 payments
  3. Azstarys $466 30 payments
  4. CAPLYTA $393 20 payments
  5. ABILIFY MAINTENA $391 22 payments
  6. REXULTI $387 19 payments
  7. JORNAY PM $347 19 payments
  8. SPRAVATO $331 16 payments
  9. TRINTELLIX $236 14 payments
  10. VRAYLAR Neuroscience $216 12 payments
  11. Other $4,032 205 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Psychiatry & Neurology: 100

Drug cost

$175

Median for Psychiatry & Neurology: $2,986

Branded share of claims

0%

Median for Psychiatry & Neurology: 16.2%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Sertraline Hcl Generic 12 $175

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 10,755 Part D prescribers listed as Psychiatry & Neurology; they describe a distribution and say nothing about conduct.

Records

360 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record